Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Glass House Brands Inc. (GLAS) Profit Margins

Source: SEC EDGAR filings · read by EquiReason

GLASGlass House Brands Inc.Follow GLAS — free
Drug Manufacturers - Specialty & Generic · Healthcare
—
Price chart with a free account
Market cap
185.1M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
11 Nov, in 18 days
LineFY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Trend
Gross margin25.0%24.4%50.3%48.5%42.3%—
Operating margin-57.2%-66.4%-30.8%2.9%-9.1%—
Net margin-68.2%-38.8%-61.1%0.3%-16.3%—
FCF margin-203.8%-80.8%6.8%9.0%-8.6%—

USD millions · SEC XBRL

Every figure on this page comes from Glass House Brands Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.